Page 101 - Syndipharma
P. 101

Mofid Pharmaceutical Co. (Private Joint Stock)

            IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY




                  Founded:                   May 1973


                  HQ Office:                 No.17 (5  Floor), Pazhoheshgah (2 ) Alley, Ahmad Ghasir St, Tehran, Iran
                                                                         nd
                                                    th
                  Plant Location:            23  St., 3 Phase, Hashtgerd Industrial Park, Alborz Province, Iran
                                                     rd
                                               rd
                  Capital:                   150000000000 Rials

                  Major Shareholder:         Shafayab Gostar


                  Employees:                 140


                  Company Profile:
                  MODAVA Pharmaceutical Co. has commenced its solid manufacturing activities in 1973 with an area about 10324
                  m2 (5148 m2 of that is dedicated to the building). Company`s name has been altered to Teb-e Mofid Nikan in 2017.
                  Hitherto, Mofid is going to focus on manufacturing solid products, supplements and packaging under the license of
                  well-known companies such as Bayer and Desitin. Now, the company succeed to reach the consistent high quality
                  of products through considering GMP principles, using modern equipment and well-educated qualified employees.

                  Production Lines:
                  1) Capsule   2) Tablet    3) Sachet
                  - Under license products lines:
                  4) Primary Packaging   5) Secondary Packaging


                  Premier Partner:
                            Bayer                                                     Desitin
                            In Germany                      In Germany


                  Certificates:
                  * ISO 10015:1999 Training Department
                  * Laboratory Accreditation Certificate
                     Date:  11 April 2016__ ID Code: 051 \T-D __ No. 685/4794
                  *Grade A GMP certificate for general and hazardous line (solid dosage form) Date: 19.02.2018 Ref: 665/149774


                  Therapeutic Groups and Pharmaceuticals with Capacity for Exports:
                  Anti-Hyperlipidemia (Atorvastatin 10mg, Atorvastatin 20mg)
                   Anti-Hypertensive (Losartan 25mg, Losartan 50mg, Amlodipine 5mg)
                   Prostate Hyperplasia (Sildenafil 50mg)
                  Mucolytic (Bromhexine 8mg)
                  Bisphosphonate (Alendronate 70mg)
                  Antimalarial (Hydroxychloroquine Sulfate 200mg)
                  Antimuscarinic (solifenacin 5mg, solifenacin 10mg)
                  Alpha blocker (Tamsulosin 0.4mg)

          100
   96   97   98   99   100   101   102   103   104   105   106